Back to search

Norway· NO-ID_9B4B4DB6-119B-4603-AD08-61EB5E5B2DAD

Nevirapine aurobindo

A nevirapine product containing nevirapine, registered in Norway by Aurobindo. The same ATC class is registered in 16 of our 19 countries.

ATC J05AG01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedNevirapine aurobindoATCJ05AG01REGISTER NO.NO-ID_9B4B4DB6-119B-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Nevirapine is registered in 16 of 19 countries.

Countries holding a registration under ATC J05AG01 (nevirapine), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 9 of them publish a price we can compare per daily dose

Nevirapine · ATC J05AG01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nevirapine costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $3.81 in France to $7.77 in Switzerland — a ×2.0 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Nevirapine · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$7.77
  • FR France$3.81
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Nevirapine
Manufacturer
Aurobindo
Country
Norway (NO)
ATC code
J05AG01
ATC class
Nevirapine
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_varenummer
    366889
    240
  • gtin
    365862057242
  • no_merkevare_id
    ID_9B4B4DB6-119B-4603-AD08-61EB5E5B2DAD

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

316 interactions on record for nevirapine.

Graded by severity as the source publishes them — 26 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Nevirapine · interactions on record

316 records

  • 26 severe
  • 220 moderate
  • 8 minor
  • 49 info

Most severe, free to view

  • DeflazacortH02AB13severe
  • BrigatinibL01ED04severe
  • LorlatinibL01ED05severe
  • CobimetinibL01EE02severe

13 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nevirapine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nevirapine products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Nevirapin Viatris
  • Belgium · Nevirapine Viatris
  • Germany · Nevirapin Abdi, Nevirapin Aurobindo
  • Denmark · Nevirapine Medical Valley, Nevirapine Viatris
  • Spain · Nevirapina Aurovitas, Nevirapina Kern Pharma
  • Finland · Nevirapine Viatris
  • France · Nevirapine Arrow Lab, Nevirapine Cristers
  • United Kingdom (Northern Ireland) · Nevirapine Accord, Nevirapine Accord Healthcare
  • Greece · Nevirapine Vocate
  • Iceland · Viramune
  • Italy · Nevirapina Aurobindo, Nevirapina Mylan
  • Liechtenstein · Viramune
  • Luxembourg · Nevirapine Viatris
  • Netherlands · Nevirapine Accord, Nevirapine Amarox
  • Portugal · Nevirapina Accord, Nevirapina Aurovitas
  • Romania · Nevirapina Accord, Nevirapină Accord
  • Sweden · Nevirapine Medical Valley

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e53b5118-da9a-4559-8131-2efcdf24cea8
GET /v1/drugs/e53b5118-da9a-4559-8131-2efcdf24cea8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Mikstur, suspensjon",
  "source": "fest",
  "status": "A",
  "atc_name": "Nevirapin",
  "merkevare_id": "ID_9B4B4DB6-119B-4603-AD08-61EB5E5B2DAD",
  "name_form_strength": "Nevirapine aurobindo mikst susp 50 mg/5 ml",
  "prescription_group": "C"
}

See everything about nevirapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.